We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-12.56%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$1.42B
AUM Growth
Cap. Flow
+$1.53B
Cap. Flow %
107.81%
Top 10 Hldgs %
60.32%
Holding
334
New
334
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 16.65%
2 Utilities 16.59%
3 Communication Services 9.1%
4 Consumer Discretionary 6.67%
5 Industrials 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNC icon
176
Lincoln National
LNC
$8.07B
$362K 0.03%
+7,055
New +$429K
ATH
177
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$357K 0.03%
+8,967
New +$404K
F icon
178
Ford
F
$57.5B
$352K 0.02%
+45,999
New +$410K
IDXX icon
179
Idexx Laboratories
IDXX
$43.9B
$352K 0.02%
+1,893
New +$388K
BMY icon
180
Bristol-Myers Squibb
BMY
$137B
$350K 0.02%
+6,732
New +$362K
MDP
181
DELISTED
Meredith Corporation
MDP
$344K 0.02%
+6,625
New +$359K
BAND
182
Bandwidth Inc
BAND
$1.53B
$338K 0.02%
+8,300
New +$390K
DERM
183
DELISTED
Dermira, Inc.
DERM
$337K 0.02%
+46,811
New +$512K
MKL icon
184
Markel Group
MKL
$22.2B
$336K 0.02%
+324
New +$354K
PCRX icon
185
Pacira BioSciences
PCRX
$983M
$335K 0.02%
+7,786
New +$363K
ANSS
186
DELISTED
Ansys
ANSS
$332K 0.02%
+2,320
New +$360K
JLL icon
187
Jones Lang LaSalle
JLL
$17.8B
$327K 0.02%
+2,580
New +$349K
CLH icon
188
Clean Harbors
CLH
$16.7B
$326K 0.02%
+6,604
New +$411K
ALGT icon
189
Allegiant Air
ALGT
$2.24B
$324K 0.02%
+3,235
New +$386K
STOR
190
DELISTED
STORE Capital Corporation
STOR
$318K 0.02%
+11,235
New +$327K
HRC
191
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$312K 0.02%
+3,525
New +$320K
PM icon
192
Philip Morris
PM
$293B
$309K 0.02%
+4,636
New +$387K
PDM
193
Piedmont Realty Trust
PDM
$1.21B
$305K 0.02%
+17,880
New +$325K
PRU icon
194
Prudential Financial
PRU
$41.8B
$304K 0.02%
+3,732
New +$344K
NBEV
195
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$302K 0.02%
+58,100
New +$305K
CBRE icon
196
CBRE Group
CBRE
$44B
$301K 0.02%
+7,518
New +$311K
SIVB
197
DELISTED
SVB Financial Group
SIVB
$299K 0.02%
+1,575
New +$385K
IONS icon
198
Ionis Pharmaceuticals
IONS
$9.93B
$297K 0.02%
+5,500
New +$281K
TSLX icon
199
Sixth Street Specialty
TSLX
$1.79B
$297K 0.02%
+16,400
New +$325K
ASAP
200
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$294K 0.02%
+1,320
New +$300K

Similar funds

Michael Gelband's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Michael Gelband, which disclosed 334 positions worth $1.42B. Its ten largest holdings account for 60% of the portfolio.

Its largest position is State Street SPDR S&P 500 ETF Trust: 1,189,219 shares worth $297M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Utilities and Communication Services.

  • Michael Gelband's largest Q4 2018 buy was State Street SPDR S&P 500 ETF Trust: 1,189,219 shares worth $297M.
  • Michael Gelband's ten largest holdings make up 60% of its $1.42B portfolio in Q4 2018.
  • Michael Gelband disclosed 334 positions in Q4 2018, its first 13F filing on record.

Based on ExodusPoint Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.